▲Wirig Diagram Hot
▲ ▲ ▼

What is Papillary Renal Cell Carcinoma

By

Papillary renal cell carcinoma (PRCC) is one of the most common types of kidney cancer, accounting for approximately 10-15% of all renal cell carcinomas (RCC). It's characterized by finger-like growths or branches (called papillae) that line the insides of the kidney's renal tubules. Unlike other types of kidney cancer, PRCC tends to grow slower and may have a better prognosis.

PRCCs can be classified into two types based on their growth patterns and microscopic appearance: type 1, which is more common and usually grows slower, and type 2, which is less common and tends to grow faster. Understanding the type of PRCC helps doctors plan the most appropriate treatment.

Symptoms and Detection

PRCC often doesn't cause any symptoms in its early stages. When symptoms do appear, they can include:

Renal cell Carcinoma
Renal cell Carcinoma
RENAL CELL CARCINOMA - pediagenosis
RENAL CELL CARCINOMA - pediagenosis
Renal Cell Carcinoma
Renal Cell Carcinoma
  • Blood in urine (hematuria), which may cause urine to appear red, brown, or tea-colored.
  • Pain in the side or back,often just below the ribs.
  • Lump or mass in the side or belly.
  • Weight loss, fever, or fatigue.

If PRCC is suspected, doctors typically use imaging tests such as X-rays, CT scans, or MRIs to confirm the diagnosis. A tissue sample (biopsy) may also be taken for laboratory examination.

Grading and Staging

After a PRCC diagnosis, doctors determine its grade, which estimates how different the cancer cells are from normal cells, and its stage, which describes the extent of cancer's spread. This information helps decide on the best treatment plan.

Papillary Left Renal Cell Carcinoma
Papillary Left Renal Cell Carcinoma
Renal Cell Carcinoma Treatment Journey: From Diagnosis to Recovery
Renal Cell Carcinoma Treatment Journey: From Diagnosis to Recovery
Papillary Renal Cell Carcinoma (RCC) Left Kidney and Hepatic Hemangioma
Papillary Renal Cell Carcinoma (RCC) Left Kidney and Hepatic Hemangioma

PRCCs are often graded using the Fuhrman nuclear grading system, which ranges from I (low grade) to IV (high grade). Staging is typically done using the TNM system, which considers the tumor's size, extent of spread to nearby lymph nodes (if any), and the presence of distant metastasis (spread to other parts of the body).

Causes and Risk Factors

The exact cause of PRCC is not known, but some risk factors have been identified. These include:

  • Gender: Men are more likely to develop PRCC than women.
  • Age: PRCC is more common in people over 50.
  • Verfahren - Böcher - Dieckerhoff syndrome (VBD): People with this inherited condition have a higher risk of developing PRCC.
  • Smoking and obesity.

Knowing these risk factors can help in early detection and management of PRCC. Regular check-ups, a healthy lifestyle, and avoiding known risk factors can lower the chances of developing this type of kidney cancer.

What Is Chromophobe Renal Cell Carcinoma?
What Is Chromophobe Renal Cell Carcinoma?
Renal Cell Carcinoma (RCC) & Pediatric Tumors 🎗️
Renal Cell Carcinoma (RCC) & Pediatric Tumors 🎗️
The Effects of Metastatic Renal Cell Carcinoma on the Body
The Effects of Metastatic Renal Cell Carcinoma on the Body
The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma (05.09.2016)
The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma (05.09.2016)
Sample Pages for Advanced Renal Cell Carcinoma
Sample Pages for Advanced Renal Cell Carcinoma
What is Renal Cell Carcinoma and How Is It Treated?
What is Renal Cell Carcinoma and How Is It Treated?

Treatment Options

Treatment for PRCC depends on various factors, including the size, stage, grade, and location of the tumor, as well as the patient's overall health. Common treatments include:

  • Surgery: This is the most common treatment for PRCC. The doctor may remove the entire kidney (nephrectomy) or just the cancer and a small amount of normal tissue around it (partial nephrectomy).
  • Chemotherapy, radiation therapy, and targeted therapy: These may be used if the cancer has spread beyond the kidney or if surgery is not an option.However, PRCCs are typically not very responsive to chemotherapy compared to other types of kidney cancer.

Clinical trials may also be an option for some patients. It's important to discuss all treatment options with a healthcare team to decide on the best course of action.

Living with PRCC and its treatment can be challenging, but support from healthcare teams, family, and friends can make a significant difference. Keeping regular follow-ups, maintaining a healthy lifestyle, and staying positive are crucial for managing cancer and its side effects.

💬 Comments ↗ Share ★ Save
AD